Your welcome. Yeah it's hard to time these things. I'm lucky I found this gem when it was boring at 70 cents. Although technical analysis may not be the most effective route with biotecs, without news you may want to consider the RSI. When it's overbought without any news, I'd sell some of my position. It sometimes kind of works but never perfectly.
Volatility may allow you the opportunity to buy back in lower. I'm still holding all my shares at this point. News on the way. Investor conferences will bring in new money plus partnership news. Plus trial updates, analyst buy recommendations... to much to list all.
News 
Market Data 
Discover 
